Showing results (391-400 of 483) with videos related to
Sort By:
Pageof 49
Nature|June 3, 1999
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysisP H Maxwell, M S Wiesener, G W Chang, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|November 15, 2008
Variations within oxygen-regulated gene expression in humansJerome T S Brooks, Gareth P Elvidge, Louisa Glenny, et al.Nature|June 7, 2002
Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHLWai-Ching Hon, Michael I Wilson, Karl Harlos, et al.Melanoma Research|August 28, 1999
Overexpression of mutant ras in human melanoma increases invasiveness, proliferation and anchorage-independent growth in vitro and induces tumour formation and cachexia in vivoM Fujita, D A Norris, H Yagi, et al.Oncotarget|March 19, 2016
Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinomaRafia S Al-Lamki, Jun Wang, Jun Yang, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 13, 2004
Persistent induction of HIF-1alpha and -2alpha in cardiomyocytes and stromal cells of ischemic myocardiumJan Steffen Jürgensen, Christian Rosenberger, Michael S Wiesener, et al.Cell Reports|July 12, 2024
Hypoxia drives HIF2-dependent reversible macrophage cell cycle entryBo Meng, Na Zhao, Petra Mlcochova, et al.Molecular and Cellular Biology|June 21, 2005
Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinomaRaju R Raval, Kah Weng Lau, Maxine G B Tran, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 31, 2025
Pre-radiotherapy multidisciplinary survivorship care and patient-reported outcomes in head and neck cancer survivorsFendi Obuekwe, Jinhong Li, Susan M Sereika, et al.Clinical Journal of the American Society of Nephrology : CJASN|May 14, 2011
Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigreesYiannis Athanasiou, Konstantinos Voskarides, Daniel P Gale, et al.Pageof 49